{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:22:44Z","timestamp":1790076164491,"version":"4.0.1"},"reference-count":20,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2016,12,21]]},"abstract":"<jats:p>Angioedema (AE) of the upper airways is a severe and potentially life-threatening condition. The incidence has been increasing in the past two decades, primarily due to increased use of medications inhibiting the degradation of vasoactive peptides. Acquired angioedema related to angiotensin-converting enzyme inhibitors (ACEI-AAE) is well known, but other pharmaceutical agents also affect the degradation of bradykinin and substance P. We present a middle-aged man with recurrent episodes of severe AE of the oral cavity, hypopharynx and larynx due to pharmacological inhibition of dipeptidyl peptidase IV.<\/jats:p>","DOI":"10.1136\/bcr-2016-217802","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T15:23:12Z","timestamp":1484061792000},"page":"bcr2016217802","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Recurrent angioedema associated with pharmacological inhibition of dipeptidyl peptidase IV"],"prefix":"10.1136","volume":"2017","author":[{"given":"Thorbj\u00f8rn","family":"Hermanrud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Bygum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Rye","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,1,10]]},"reference":[{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.1","doi-asserted-by":"publisher","DOI":"10.1159\/000354543"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.2","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.12.0470"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.3","first-page":"A4449","article-title":"Increasing rate of angiotensin-converting enzyme inhibitor-related upper airway angio-oedema","volume":"59","author":"Holm","year":"2012","journal-title":"Dan Med J"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.4","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.134197"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.5","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2010.2.3.195"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.6","unstructured":"WHO. Global report on diabetes. Published Online First: 2016. http:\/\/apps.who.int\/iris\/bitstream\/10665\/204874\/1\/WHO_NMH_NVI_16.3_eng.pdf?ua=1"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.7","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1517\/14656566.2015.1114098","article-title":"Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus","volume":"16","author":"Triplitt","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-9781(96)00201-X"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-0115(99)00089-0"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.10","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.31.6.1299"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.peptides.2015.11.004","article-title":"Neuropeptide Y is a physiological substrate of fibroblast activation protein: enzyme kinetics in blood plasma and expression of Y2R and Y5R in human liver cirrhosis and hepatocellular carcinoma","volume":"75","author":"Wong","year":"2016","journal-title":"Peptides"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705452"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(02)00173-X"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.14","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.096552"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.15","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(01)00031-0"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.16","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aes364"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0002-9343(91)80179-P","article-title":"Contraindications to the use of ace inhibitors in patients with C1-esterase inhibitor deficiency","volume":"90","author":"Agostoni","year":"1991","journal-title":"Am J Med"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.18","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e328362b835"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1749-8"},{"key":"2025042702235686000_2017.jan10_2.bcr2016217802.20","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.110270"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2016-217802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T09:24:10Z","timestamp":1745745850000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2016-217802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,10]]},"references-count":20,"alternative-id":["10.1136\/bcr-2016-217802"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2016-217802","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,10]]}}}